Neogen ROE 2010-2024 | NEOG
Current and historical return on equity (ROE) values for Neogen (NEOG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Neogen ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-08-31 | $-0.02B | $3.14B | -0.73% |
| 2024-05-31 | $-0.01B | $3.14B | -0.25% |
| 2024-02-29 | $0.00B | $3.15B | 0.10% |
| 2023-11-30 | $0.01B | $3.15B | 0.41% |
| 2023-08-31 | $-0.03B | $3.15B | -0.83% |
| 2023-05-31 | $-0.02B | $3.13B | -0.90% |
| 2023-02-28 | $-0.01B | $3.13B | -0.70% |
| 2022-11-30 | $-0.02B | $3.11B | -1.18% |
| 2022-08-31 | $0.04B | $0.88B | 4.10% |
| 2022-05-31 | $0.05B | $0.89B | 5.51% |
| 2022-02-28 | $0.05B | $0.88B | 5.70% |
| 2021-11-30 | $0.06B | $0.87B | 6.77% |
| 2021-08-31 | $0.06B | $0.86B | 7.56% |
| 2021-05-31 | $0.06B | $0.84B | 7.68% |
| 2021-02-28 | $0.06B | $0.81B | 7.97% |
| 2020-11-30 | $0.06B | $0.78B | 8.09% |
| 2020-08-31 | $0.06B | $0.75B | 8.33% |
| 2020-05-31 | $0.06B | $0.73B | 8.46% |
| 2020-02-29 | $0.06B | $0.71B | 8.74% |
| 2019-11-30 | $0.06B | $0.69B | 9.20% |
| 2019-08-31 | $0.06B | $0.66B | 9.52% |
| 2019-05-31 | $0.06B | $0.64B | 9.83% |
| 2019-02-28 | $0.06B | $0.62B | 10.49% |
| 2018-11-30 | $0.07B | $0.60B | 11.55% |
| 2018-08-31 | $0.07B | $0.58B | 12.15% |
| 2018-05-31 | $0.06B | $0.56B | 12.13% |
| 2018-02-28 | $0.06B | $0.54B | 11.47% |
| 2017-11-30 | $0.05B | $0.52B | 10.56% |
| 2017-08-31 | $0.05B | $0.49B | 9.75% |
| 2017-05-31 | $0.04B | $0.47B | 9.68% |
| 2017-02-28 | $0.04B | $0.45B | 9.60% |
| 2016-11-30 | $0.04B | $0.44B | 9.49% |
| 2016-08-31 | $0.04B | $0.42B | 9.33% |
| 2016-05-31 | $0.04B | $0.40B | 9.38% |
| 2016-02-29 | $0.04B | $0.39B | 9.44% |
| 2015-11-30 | $0.03B | $0.38B | 9.50% |
| 2015-08-31 | $0.03B | $0.37B | 9.56% |
| 2015-05-31 | $0.03B | $0.35B | 9.90% |
| 2015-02-28 | $0.03B | $0.34B | 9.93% |
| 2014-11-30 | $0.03B | $0.33B | 10.30% |
| 2014-08-31 | $0.03B | $0.32B | 10.02% |
| 2014-05-31 | $0.03B | $0.31B | 10.09% |
| 2014-02-28 | $0.03B | $0.29B | 10.16% |
| 2013-11-30 | $0.03B | $0.28B | 10.60% |
| 2013-08-31 | $0.03B | $0.27B | 11.45% |
| 2013-05-31 | $0.03B | $0.26B | 11.53% |
| 2013-02-28 | $0.03B | $0.25B | 11.59% |
| 2012-11-30 | $0.03B | $0.24B | 11.16% |
| 2012-08-31 | $0.02B | $0.23B | 10.69% |
| 2012-05-31 | $0.02B | $0.22B | 10.62% |
| 2012-02-29 | $0.02B | $0.21B | 11.01% |
| 2011-11-30 | $0.02B | $0.20B | 11.47% |
| 2011-08-31 | $0.02B | $0.20B | 12.50% |
| 2011-05-31 | $0.02B | $0.19B | 13.14% |
| 2011-02-28 | $0.02B | $0.18B | 13.25% |
| 2010-11-30 | $0.02B | $0.17B | 13.29% |
| 2010-08-31 | $0.02B | $0.16B | 13.29% |
| 2010-05-31 | $0.02B | $0.15B | 12.50% |
| 2010-02-28 | $0.02B | $0.15B | 11.59% |
| 2009-11-30 | $0.02B | $0.14B | 11.30% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.270B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.157B | 25.91 |
| Stryker (SYK) | United States | $148.171B | 33.39 |
| Boston Scientific (BSX) | United States | $133.131B | 38.28 |
| EssilorLuxottica (ESLOY) | France | $113.461B | 0.00 |
| Medtronic (MDT) | Ireland | $109.010B | 16.19 |
| Haleon (HLN) | United Kingdom | $42.913B | 27.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.122B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.701B | 19.56 |
| ResMed (RMD) | United States | $34.955B | 28.72 |
| Terumo (TRUMY) | Japan | $29.203B | 41.24 |
| Koninklijke Philips (PHG) | Netherlands | $24.410B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.087B | 14.06 |
| Insulet (PODD) | United States | $18.377B | 73.18 |
| Baxter (BAX) | United States | $16.604B | 10.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.153B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.468B | 37.96 |
| Bio-Rad Laboratories (BIO) | United States | $8.977B | 30.51 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.523B | 12.83 |
| TG Therapeutics (TGTX) | United States | $4.720B | 0.00 |
| Haemonetics (HAE) | United States | $4.260B | 20.79 |
| ICU Medical (ICUI) | United States | $4.155B | 39.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.074B | 20.26 |
| Perrigo (PRGO) | Ireland | $3.716B | 10.94 |
| Envista Holdings (NVST) | United States | $3.487B | 25.97 |
| Agios Pharmaceuticals (AGIO) | United States | $3.103B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.789B | 17.89 |
| QuidelOrtho (QDEL) | United States | $2.595B | 16.70 |
| Warby Parker (WRBY) | United States | $2.344B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.332B | 56.69 |
| Green Thumb Industries (GTBIF) | United States | $1.964B | 34.37 |
| AtriCure (ATRC) | United States | $1.772B | 0.00 |
| InMode (INMD) | Israel | $1.487B | 8.94 |
| Curaleaf Holdings (CURLF) | Canada | $1.348B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.311B | 9.37 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.168B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.957B | 7.48 |
| CeriBell (CBLL) | United States | $0.916B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.888B | 29.68 |
| Capricor Therapeutics (CAPR) | United States | $0.839B | 0.00 |
| Evolus (EOLS) | United States | $0.785B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.608B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.596B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.596B | 26.47 |
| Surmodics (SRDX) | United States | $0.559B | 0.00 |
| Quanterix (QTRX) | United States | $0.424B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.404B | 0.00 |
| Valneva SE (VALN) | France | $0.370B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.63 |
| Omeros (OMER) | United States | $0.349B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.335B | 31.89 |
| Biote (BTMD) | United States | $0.330B | 7.25 |
| Sanara MedTech (SMTI) | United States | $0.323B | 0.00 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.288B | 19.30 |
| Zynex (ZYXI) | United States | $0.249B | 52.13 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.15 |
| MacroGenics (MGNX) | United States | $0.218B | 0.00 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| Sanuwave Health (SNWV) | United States | $0.195B | 2.74 |
| Jin Medical (ZJYL) | China | $0.188B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.162B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 96.70 |
| Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.98 |
| TriSalus Life Sciences (TLSI) | United States | $0.126B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 10.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.00 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.082B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.080B | 41.50 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.066B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| Exagen (XGN) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.026B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.17 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |